account supervisor, Area 23
Taylor Bicchieri has earned the reputation as a launch leader and portfolio expert, able to build brands from the ground up and think strategically about how every tactic fits into a bigger picture. Her work spans several therapeutic areas, including neurology, allergy, asthma, gastroenterology, and over-the-counters for both U.S. and global teams.
During her tenure on the Lilly ad platform team at Area 23, Bicchieri supported all aspects of the business across both solanezumab and Amyvid, global and U.S. She led the launch of the biomedicines business unit’s first direct marketing campaign. The latter was aimed at educating imaging physicians and dementia specialists about the IDEAS study, designed to determine the clinical usefulness and impact on patient outcomes of a PET scan to detect amyloid plaques in patients with mild cognitive impairment. The campaign was recognized by Eli Lilly senior